Outreach, Screening, and Randomization of APOE ε4 Carriers into an Alzheimer&#39;s Prevention Trial: A global Perspective from the API Generation Program.

umibecestat (CNP520) - Novartis, Amgen, Banner Alzheimer’s Institute

amilomotide (CAD106) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/37357285

A Graf; B Borowsky; C Lopez Lopez; D Gordon; F Liu; I Scholten; J Arbuckle; J B Langbaum; J Ricart; K Doak; L Duff; M Quinn; M Smith; M-E Riviere; P C Arratia; P N Tariot; T Walsh

Jun 26, 2023